KZA 0.00% 8.0¢ kazia therapeutics limited

Ann: Interim data from MSKCC study, page-25

  1. 856 Posts.
    lightbulb Created with Sketch. 356
    Kazia is not the primary investigator for this trial, so they don't control the data. Its release is dependent upon the rules of the publishing publication, etc.
 
watchlist Created with Sketch. Add KZA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.